阿里健康与辉瑞达成战略合作 聚焦偏头痛治疗

中国网财经
Nov 07

中国网财经11月7日讯今日在“第八届中国国际进口博览会”上,阿里健康与辉瑞达成战略合作。  双方将围绕偏头痛治疗领域,在创新药品可及性、数字化疾病管理、患者教育及全链路健康服务等方面展开深度协同,以辉瑞全新一代偏头痛特异性治疗药物瑞美吉泮口崩片(乐泰可)在中国的加速落地为起点,共同探索“医-药-患”一体化的数字健康新模式。  偏头痛是全球第二大常见神经系统失能性疾病,也是50岁以下人群首要致残原因...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10